RedCarpetLife
578
In the world today
Rudolf Maag

Rudolf Maag

R. Maag
1.14% | + $75.96M
$6.73 B ₹ 65,121 Cr
Real Time Net Worth #578 Ranking as of 20 May 2026 By Forbes

More on Rudolf Maag

Gender

Male

Age

80Y

Country

Switzerland

Born On

January, 1946

Deceased

No

Relationship Status

Married

Children

2

Education

INSEAD - MBA

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Medical Devices)

Primary Organization

Synthes

Titles

Former Shareholder

Sources of Wealth

Medical Devices

Industry

Healthcare, Medical Devices

About Rudolf Maag


R udolf Maag is a Swiss billionaire entrepreneur who built his fortune in the medical devices industry. After earning an MBA from INSEAD, he began his career at Sandoz AG before joining the dental implant company Straumann. In a career-defining move in 1990, he acquired Straumann's medical device division, which he later spun off and listed as Stratec Medical. He successfully merged Stratec with Synthes, a global leader in orthopedic devices, in 1999.

Maag became a major shareholder in the combined entity, Synthes-Stratec, eventually holding a 15% stake. When Johnson & Johnson acquired Synthes for nearly $20 billion in 2012, Maag cashed out, solidifying his billionaire status. Since then, he has focused on investing his wealth in various sectors, including pharmaceuticals, construction, and hospitality (owning the Bellevue Hotel). He is also a notable philanthropist, supporting arts and cultural institutions in Switzerland.

Advertisement

Quick Reads


Early Life and Background


Rudolf Maag is a Swiss businessman whose fortune stems from his ventures in medical devices.

Maag earned an M.B.A. from Insead in 1973 and began his career at pharmaceutical company Sandoz AG of Switzerland. He later moved to dental giant Straumann, where, in 1990, he bought out the medical device division and took it public as Stratec Medical.

  • Core Industry: Medical devices.
  • Education: Holds an M.B.A. from Insead (1973).
  • Strategic Move: In 1990, he bought out the medical device division of Straumann and took it public as Stratec Medical.

Career Journey of Rudolf Maag


Rudolf Maag's career is marked by his strategic restructuring and consolidation within the European medical device industry. After founding Stratec Medical from a leveraged buyout in 1990, he later engineered a major deal in 1999 by merging Stratec with Swiss medical device powerhouse Synthes.

Through this deal, Maag built up a significant 15% stake in Synthes, which was later sold to Johnson & Johnson, securing his billionaire status from the successful acquisition and exit.

  • Key Merger: Merged Stratec with Swiss medical device powerhouse Synthes in 1999.

Advertisement

Rudolf Maag's Timeline


1973:

Got an M.B.A. from Insead.

1990:

Bought out the medical device division of Straumann and took it public as Stratec Medical.

1999:

Merged Stratec with Synthes.

Ongoing:

Synthes was later sold to Johnson & Johnson.

Major Business Ventures and Investments


Rudolf Maag's wealth is concentrated in the proceeds from the sale of his stake in the consolidated medical device entity.

  • Stratec Medical (Founder): Founded from a buyout of Straumann's medical device division.
  • Synthes (Former Stakeholder): Held a 15% stake after the Stratec merger, which was later sold to Johnson & Johnson.
  • Prior Experience: Worked at pharmaceutical company Sandoz AG.

Advertisement

Philanthropy and Social Impact


Fashion, Style, and Lifestyle


Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • His fortune stems from the medical devices industry.
  • He founded Stratec Medical after a buyout in 1990.
  • He later built up a 15% stake in Synthes, which was sold to Johnson & Johnson.

Advertisement

More Profiles


Jared Smith

0% | $0.00M

Robert Ziff

+6% | +$406.91M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content